Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma
<p><strong>Background:</strong> The most recognizable phenotype of severe asthma comprises people who are blood eosinophil and FeNO-high, driven by type-2 (T2) cytokine biology which responds to targeted biological therapies. However, in many people with severe asthma, these T2 bio...
Hoofdauteurs: | Khalfaoui, L, Symon, F, Couillard, S, Hargadon, B, Chaudhuri, R, Bicknell, S, Mansur, A, Shrimanker, R, Hinks, T, Pavord, I, Fowler, S, Brown, V, McGarvey, L, Heaney, L, Austin, C, Howarth, P, Arron, J, Choy, D, Bradding, P |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Wiley
2022
|
Gelijkaardige items
-
FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
door: Couillard, S, et al.
Gepubliceerd in: (2021) -
FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
door: Couillard, S, et al.
Gepubliceerd in: (2021) -
Mast-cell infiltration of airway smooth muscle in asthma.
door: Brightling, C, et al.
Gepubliceerd in: (2002) -
The effects of inhaled corticosteroids on healthy airways
door: Marchi, E, et al.
Gepubliceerd in: (2024) -
Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework
door: Couillard, S, et al.
Gepubliceerd in: (2022)